ArticleOrphanet journal of rare diseases2025

Open-label pilot study using hydroxytyrosol as dietary supplements in patients with mitochondrial diseases.

Tsz Sum Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.